Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 14619456

Intravenous ascorbic acid: protocol for its application and use.

Hugh D Riordan·Ronald B Hunninghake·Neil H Riordan·James J Jackson·Xiaolong Meng·Paul Taylor·Joseph J Casciari·Michael J González·Jorge R Miranda-Massari·Edna M Mora·Norberto Rosario·Alfredo Rivera
View original source ↗Export metadata ↓

Abstract

High dose intravenous(i.v.) ascorbic acid (AA) has been used as therapy for infectious disease from bacterial and viral origin and adjuvant therapy for cancer. In this publication we describe a clinical protocol that has been developed over the past twenty years utilizing high dose i.v. AA as therapy for cancer. This includes principles of treatment, rationale, baseline workup, infusion protocol, precautions and side effects.

Explore related subjects

Anti-Infective AgentsAntineoplastic AgentsAscorbic AcidBacterial InfectionsClinical ProtocolsDose-Response Relationship, DrugHumansInfusions, IntravenousNeoplasmsNeoplastic Stem CellsVirus DiseasesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hugh D Riordan, Ronald B Hunninghake, Neil H Riordan, James J Jackson, Xiaolong Meng, Paul Taylor, Joseph J Casciari, Michael J González, Jorge R Miranda-Massari, Edna M Mora, Norberto Rosario, Alfredo Rivera. 2003. Intravenous ascorbic acid: protocol for its application and use.. https://pubmed.ncbi.nlm.nih.gov/14619456/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Chemical composition and antimicrobial activity of volatile compounds of Tamarix boveana (Tamaricaceae).

The chemical composition of the Tamarix boveana volatile oils obtained from the whole aerial part, flowers, leaves and stems by steam distillation was analysed using gas chromatograph (GC)-flame ionization detectors (FID) and GC-MS. Sixty-two components were identified. Hexadecanoic acid (18.14%), docosane (13.34%), germacrene D (7.68%), fenchyl acetate (7.34%), Benzyl benzoate (4.11%) were found to be the major components in the whole aerial parts. This composition differed according to the tested part: 2.4 Nonadienal was the main compound in the flowers (12.13%) while germacrene D was the major component in leaves (31.43%) and hexadecanoic acid in the stems (13.94%). To evaluate in vitro antimicrobial activity, all volatile oils were tested against six Gram-positive and Gram-negative bacteria and four fungi. The T. boveana volatile oils exhibited an interesting antibacterial activity against all strains tested except Pseudomonas aeruginosa but no antifungal activity was detected.

Anti-Infective Agents↗
PubMed2007

Role of human neutrophil peptides in the initial interaction between lung epithelial cells and CD4+ lymphocytes.

Human neutrophil peptides (HNP) exert immune-modulating effects. We hypothesized that HNP link innate and adaptive immunity through activation of costimulatory molecules. Human lung epithelial cells and CD4+ lymphocytes were treated with HNP separately or in coculture. Stimulation with HNP induced an increase in cell surface expression of CD54 (ICAM-1), CD80, and CD86 on lung epithelial cells and the corresponding major ligands, CD11a (LFA-1), CD152 (CTLA-4), and CD28 on CD4+ lymphocytes. There was an increased nuclear expression of the transcription factor p53 in human alveolar A549 cells and an elevated NF-kappaB (p50) and a degradation of I-kappaB protein in CD4+ lymphocytes following HNP stimulation. HNP enhanced the interaction between A549 cells and CD4+ lymphocytes by increasing cell adhesion and release of IFN-gamma, IL-2, and IL-8. This was attenuated by using an alpha1-proteinase inhibitor to neutralize HNP. We conclude that HNP play an important role in linking innate to acquired immunity by activation of costimulatory molecules in lung epithelial cells and CD4+ lymphocytes.

Anti-Infective Agents↗